本公司产品仅供体外研究使用,不用于临床诊断

Cell Cycle Assay Kit (Red Fluorescence)

  • 中文名称:细胞周期检测试剂盒(红色荧光)

  • 货号:E-CK-A351

订购 E-CK-A351

规格:
  • 20Assays
  • 50Assays
  • 100Assays
价格: ¥180¥126
数量:

检测原理

细胞周期(cell cycle)是指连续分裂细胞从一次有丝分裂结束到下一次有丝分裂结束所经历的整个过程。在这个过程中,细胞遗传物质复制并加倍,且在分裂结束时平均分配到两个子细胞中去。细胞周期又可以分为间期(interphase)和有丝分裂期(M phase),细胞间期又常划分为休眠期(G0),DNA合成前期(G1),DNA合成期(S),DNA合成后期(G2)。DNA周期检测可用来反应细胞周期的各个期的状况,即细胞增殖状况。利用细胞内DNA能够和荧光染料(如碘化丙啶—PI)结合的特性,细胞各个时期其DNA含量不同从而结合的荧光染料不同,流式细胞仪检测的荧光强度也不一样可检测细胞不同周期。 细胞发生凋亡时,由于胞浆和染色质浓缩、核裂解,产生凋亡小体,使细胞的光散射性质发生变化。在细胞凋亡的早期,细胞前向光散射能力显著降低,侧向光散射能力增加或没有变化。在细胞凋亡的晚期,前向和侧向散射的信号均降低。因此可通过流式细胞仪测定细胞光散射的变化观察凋亡细胞。 PI染色后,假设G0/G1期细胞的荧光强度为1,那么含有双份基因组DNA的G2/M期细胞的荧光强度的理论值为2,正在进行DNA复制的S期细胞的荧光强度为1~2之间。凋亡细胞由于细胞核发生浓缩以及DNA片段化(DNA fragmentation)导致部分基因组DNA片段在染色过程中丢失,因此凋亡细胞碘化丙啶染色后呈现明显的弱染,即荧光强度小于1,在流式检测的荧光图上出现所谓的sub-G1峰,即凋亡细胞峰。

基本信息

应用类型 细胞周期
检测方法 荧光
样本类型 细胞
检测时间 3 hours
检测仪器 流式细胞仪
荧光 PI
Ex/Em (nm) 536/617
Channel set PI,PerCP,PE
自备试剂 无水乙醇,PBS(E-IR-R187)
保存温度 2~8°C/-20°C, shading light. Refer to the Manual.
运输条件 冰袋
保质期 12 months

文献

From now on, if you have published a paper by using any of our products since 1/1/2019, fill out the “Elabscience Publication Reward Application Form”carefully and send it to orders@elabscience.com, we will get back to you with the reward after we confirm it ASAP!

View more details about our Publication Reward >>

  1. WATER RESEARCH (2020) IF: 9.1300
    Comparative toxicity reduction potential of UV/sodium percarbonate and UV/hydrogen peroxide treatments for bisphenol A in water: An integrated analysis using chemical, computational, biological, and metabolomic approaches

    DOI: 10.1016/j.watres.2020.116755

    PMID: 33383346

  2. Molecular Therapy-Nucleic Acids (2020) IF: 7.032
    Transient transfection of the respiratory epithelium with gamma interferon for host-directed therapy in pulmonary tuberculosis

    DOI: 10.1016/j.omtn.2020.10.023

    PMID: 33110704

    Sample: Tissue Slice
  3. BIOMEDICINE & PHARMACOTHERAPY (2022) IF: 7.419
    Efficacy of WWQ-131, a highly selective JAK2 inhibitor, in mouse models of myeloproliferative neoplasms

    DOI: 10.1016/j.biopha.2022.113884

    PMID: 36306591

  4. BIOFACTORS (2021) IF: 6.113
    FERM domain-containing protein 6 exerts a tumor-inhibiting role in thyroid cancer by antagonizing oncogenic YAP1

    DOI: 10.1002/biof.1791

    PMID: 34669997

  5. JOURNAL OF CELLULAR PHYSIOLOGY (2022) IF: 6.513
    IGF2BP2, an RNA-binding protein regulates cell proliferation and osteogenic differentiation by stabilizing SRF mRNA

    DOI: 10.1002/jcp.30919

  6. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2023) IF: 5.19
    N-acetylcysteine rescues meiotic arrest during spermatogenesis in mice exposed to BDE-209

    DOI: 10.1007/s11356-023-25874-0

  7. BIOORGANIC CHEMISTRY (2023) IF: 5.307
    Inspired by bis-β-carboline alkaloids: Construction and antitumor evaluation of a novel bis-β-carboline scaffold as potent antitumor agents

    DOI: 10.1016/j.bioorg.2023.106401

  8. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023) IF: 5.756
    Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation

    DOI: 10.1080/14756366.2022.2155815

  9. Pharmaceuticals (2021) IF: 5.863
    Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal SHP-1 and SOCS-3 Hypermethylation: In Vitro and In Silico Evaluation

    DOI: 10.3390/ph14121287

  10. ENVIRONMENTAL TOXICOLOGY (2022) IF: 4.119
    Inhibition of FAM83D displays antitumor effects in glioblastoma via down-regulation of the AKT/Wnt/β-catenin pathway

    DOI: 10.1002/tox.23488

  11. TOXICOLOGY AND APPLIED PHARMACOLOGY (2022) IF: 4.219
    Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1

    DOI: 10.1016/j.taap.2022.115926

    PMID: 35182550

  12. TOXICOLOGY AND APPLIED PHARMACOLOGY (2021) IF: 4.219
    Kinesin family member 23 exerts a protumor function in breast cancer via stimulation of the Wnt/β-catenin pathway

    DOI: 10.1016/j.taap.2021.115834

    PMID: 34933054

  13. TOXICOLOGY (2021) IF: 4.221
    BDE-209 induce spermatocytes arrest at early-pachytene stage during meiotic prophase I in mice

    DOI: 10.1016/j.tox.2021.153061

    PMID: 34936917

  14. TOXICOLOGY AND APPLIED PHARMACOLOGY (2022) IF: 4.46
    Zinc finger protein 671 has a cancer-inhibiting function in colorectal carcinoma via the deactivation of Notch signaling

    DOI: 10.1016/j.taap.2022.116326

  15. TOXICOLOGY AND APPLIED PHARMACOLOGY (2022) IF: 4.46
    The inhibition of centromere protein K causes anticancer effects in breast carcinoma via effects on the FAK/PI3K/AKT/mTOR pathway

    DOI: 10.1016/j.taap.2022.116232

    PMID: 36089000

  16. BMC CANCER (2022) IF: 4.638
    Glycoprotein α-Subunit of Glucosidase II (GIIα) is a novel prognostic biomarker correlated with unfavorable outcome of urothelial carcinoma

    DOI: 10.1186/s12885-022-09884-8

    PMID: 35879690

  17. RSC Advances (2021) IF: 3.361
    New insight into the joint significance of dietary jujube polysaccharides and 6-gingerol in antioxidant and antitumor activities

    DOI: 10.1039/D1RA03640H

    PMID: 35497558

  18. PLoS One (2022) IF: 3.752
    MiR-31 improves spinal cord injury in mice by promoting the migration of bone marrow mesenchymal stem cells

    DOI: 10.1371/journal.pone.0272499

    PMID: 36067193

  19. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022) IF: 3.981
    Curcumin-loaded zein/pectin nanoparticles: Caco-2 cellular uptake and the effects on cell cycle arrest and apoptosis of human hepatoma cells (HepG2)

    DOI: 10.1016/j.jddst.2022.103497

  20. TISSUE & CELL (2022) IF: 2.466
    Deactivation of AKT/GSK-3β-mediated Wnt/β-catenin pathway by silencing of KIF26B weakens the malignant behaviors of non-small cell lung cancer

    DOI: 10.1016/j.tice.2022.101750

    PMID: 35182988

  21. Evidence-based Complementary and Alternative Medicine (2022) IF: 2.65
    Network Pharmacology Analysis, Molecular Docking, and In Vitro Verification Reveal the Action Mechanism of Prunella vulgaris L. in Treating Breast Cancer

    DOI: 10.1155/2022/5481563

    PMID: 35990843

Show AllShorten

Reviews/Q&A

  • 全部
  • 评论
  • 问答
... 展开 收起

买了该产品的人还买了